Medical specialists from Switzerland tagged as investigators in clinical trials studying Systemic Scleroderma

Total 6 results

Andrea Rubbert-Roth, MD
Seen in:
- Sankt Gallen, Kantonsspital St. Gallen
Trials:
- NCT04781543 (Principal Investigator)
Conditions:
- Diffuse Cutaneous Systemic Sclerosis;
- Sclerosis, Systemic
Britta Maurer, MD
Seen in:
- Bern (de), Bern, Inselspital Bern
Trials:
- NCT04781543 (Principal Investigator)
Conditions:
- Diffuse Cutaneous Systemic Sclerosis;
- Sclerosis, Systemic
Jean Dudler, MD
Seen in:
- Fribourg, HFR Fribourg Hôpital Cantonal
Trials:
- NCT04781543 (Principal Investigator)
Conditions:
- Diffuse Cutaneous Systemic Sclerosis;
- Sclerosis, Systemic
Oliver Distler, Prof.
Seen in:
- Zurich, University of Zurich, Department of Rheumatology
Trials:
- NCT01829126 (Principal Investigator)
- NCT01836263 (Principal Investigator)
- NCT01834157 (Principal Investigator)
- NCT01840748 (Principal Investigator)
- NCT01858259 (Principal Investigator)
Conditions:
Ulrich Walker, Prof
Seen in:
- Basel, Felix-Platter Spital
- Basel, Felix-Platter Spital, University of Basel
Trials:
- NCT01829126 (Principal Investigator)
- NCT01836263 (Principal Investigator)
- NCT01834157 (Principal Investigator)
- NCT01840748 (Principal Investigator)
- NCT01858259 (Principal Investigator)
Conditions:

Clinical Trials on Systemic Scleroderma

Northwestern University

Completed

Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma

SYSTEMIC SCLERODERMA

United States
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells (MSC)

SYSTEMIC SCLERODERMA | ALLOGENEIC MESENCHYMAL STEM CELLS | ADULT

France
Biocad

Recruiting

Clinical Study of Divozilimab in Patients With Systemic Scleroderma (LIBERIUS)

Systemic Scleroderma

Russian Federation
Rennes University Hospital

Completed

Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment (PRESSY)

Systemic Scleroderma

France
University Hospital, Lille

Recruiting

Trichoscopy and Systemic Scleroderma (TRICHLOSCLERO)

Scleroderma, Systemic

France
Michael M. Pham

Terminated

A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Systemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditions

United States
Boston University
Regeneron Pharmaceuticals

Completed

IL1-TRAP, Rilonacept, in Systemic Sclerosis

Systemic Sclerosis | Scleroderma | Diffuse Systemic Sclerosis | Diffuse Scleroderma

United States
Assistance Publique Hopitaux De Marseille

Unknown

BIOLOGICAL EXPLORATION OF THE VASCULAR FRACTION FROM THE ADIPOSE TISSUE OF PATIENTS WITH SCLERODERMIA (sclerabio)

Systemic Scleroderma

France
University Hospital, Lille

Completed

Sildenafil Effect on Digital Ulcer Healing in sClerodErma SEDUCE STUDY (SEDUCE)

Systemic Scleroderma

France
University Hospital, Strasbourg, France

Recruiting

Effect of the Use of Specific Oral Hygiene Devices on Gingival Health Among Patients With Systemic Sclerosis (ScleroBross)

Scleroderma Systemic

France

Medical specialists from Switzerland tagged as investigators in clinical trials studying Systemic Scleroderma

Clinical Trials on Systemic Scleroderma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations